There is much discussion about the possibility of using transradial artery access to help reduce door-to-balloon times in ST-elevation myocardial infarction (STEMI) patients. Northside Hospital, Tampa Bay Heart Institute in St. Petersburg, Fla., tested this theory and found transradial helped lower door-to-balloon times and hospital length-of-stay.
Cath lab volumes have gone down in recent years for several reasons, but one of the biggest reasons might be market saturation. This is certainly the case in Chicago, where nearly every hospital has a cath lab, resulting in relatively low volumes at most centers, despite the fact they are located in the largest city in the Midwest.
July 17, 2012 β Panasonic announced a new 3-D medical-grade 32-inch class monitor, the EJ-MDA32U-K. The new 3-D monitor is fully compliant with medical equipment standards, delivers exceptional 2-D and 3-D image quality, and can display multiple images from various sources at once. These combined features, paired with Panasonicβs renowned reliability, make the new monitor ideal for use in the surgical bubble.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 17, 2012 β New analysis from Frost & Sullivan, βEuropean Data Storage Market in Healthcare,β finds that the market earned revenues of $1,011.4 million in 2010 and estimates this to reach $2,473 million in 2017. The research covers hospital IT, research and imaging segments.
As the average age of the U.S. population and the number of patients at high risk for cardiovascular disease increase, the usage of cardio and endovascular stents continues to grow. Interventional cardiologists and registered nurses in the U.S. were recently asked about their perceptions and attitudes regarding current percutaneous coronary interventional (PCI) procedures and devices. They were also asked their stent brand and drug type preferences. In a statistically significant survey, they divulged which procedures and manufactures they preferred. This window into micro level stent usage offers informed insights into the overall market and reveals how dynamics between medical organizations and device manufacturers contribute to market trends.
July 17, 2012 β Arterial Remodeling Technologies (ART) reported that they have achieved a medical milestone with its Arterial Remodeling Transient DIsmantling Vascular Angioplasty (ARTDIVA) clinical trial: The successful first-in-human implantation of its novel biodegradable stent into an 61-year-old male who was suffering from a blocked coronary artery and needed a percutaneous coronary intervention (PCI).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 16, 2012 β TriReme Medical Inc. (TMI) announced today that it has received U.S. Food and Drug Administration (FDA) clearance for an expanded matrix of sizes for its unique Glider PTCA balloon catheter.
Mercator MedSystems, a medical technology company whose platform Micro-Infusion Catheter technology announced preliminary results of its DANCE clinical trial that continues to follow patients at the University of California, San Francisco (UCSF) and San Francisco VA Medical Center. The technology offers catheter-guided, microfluid injection systems for site-specific, nonsystemic delivery of therapeutic agents directly across any peripheral or coronary blood vessel to treat peripheral vascular diseases, cancer, heart attacks, and other life-threatening diseases and disorders.
July 16, 2012 β The American College of Cardiology (ACC) and the American College of Radiology (ACR) are warning that the extreme cuts to funding for medical imaging scans in the 2013 Medicare Physician Fee Schedule Proposed Rule are unnecessary, unfounded and will undermine patient care.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 16, 2012 β Reva Medical Inc. announced it completed clinical enrollment with the ReZolve drug-eluting bioresorbable scaffold. A total of 26 patients have been enrolled and there are no major adverse coronary events (MACE) reported to date.
July 16, 2012 β LipoScience Inc., an in vitro diagnostic company developing clinical diagnostic tests using nuclear magnetic resonance (NMR) technology, announced publication of the findings of a clinical study in the current issue of the Journal of the American College of Cardiology indicating that high density lipoprotein (HDL) particle number has a stronger, more independent association with coronary heart disease and carotid atherosclerosis than HDL cholesterol (HDL-C).
July 16, 2012 β Medical imaging has always been an important part of clinical trials. Echocardiography, which uses sound waves to create moving real-time images of cardiac structure and function, provides an excellent noninvasive method to evaluate the impact of therapeutics on cardiac morphology.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 16, 2012 β The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $4.78 million grant to researchers at Cleveland Clinicβs Lerner Research Institute to use metabolomics β a new approach that focuses on the small-molecule byproducts of metabolism β for discovery of novel pathways linked to the development of cardiovascular diseases.
July 16, 2012 β Cardiosolutions Inc., an early-stage company focused on the development of an innovative percutaneous system to treat patients with moderate to severe mitral valve regurgitation, today announced it has received a minority investment from Sorin Group. Sorin is a global medical device company and develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.
July 16, 2012 β The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of Alere Triage products. Identified lots may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results.